Correlation Between Ambrx Biopharma and Windtree Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ambrx Biopharma and Windtree Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ambrx Biopharma and Windtree Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ambrx Biopharma American and Windtree Therapeutics, you can compare the effects of market volatilities on Ambrx Biopharma and Windtree Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ambrx Biopharma with a short position of Windtree Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ambrx Biopharma and Windtree Therapeutics.
Diversification Opportunities for Ambrx Biopharma and Windtree Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Ambrx and Windtree is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ambrx Biopharma American and Windtree Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Windtree Therapeutics and Ambrx Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ambrx Biopharma American are associated (or correlated) with Windtree Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Windtree Therapeutics has no effect on the direction of Ambrx Biopharma i.e., Ambrx Biopharma and Windtree Therapeutics go up and down completely randomly.
Pair Corralation between Ambrx Biopharma and Windtree Therapeutics
If you would invest (100.00) in Ambrx Biopharma American on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Ambrx Biopharma American or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Ambrx Biopharma American vs. Windtree Therapeutics
Performance |
| Timeline |
| Ambrx Biopharma American |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Windtree Therapeutics |
Ambrx Biopharma and Windtree Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ambrx Biopharma and Windtree Therapeutics
The main advantage of trading using opposite Ambrx Biopharma and Windtree Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ambrx Biopharma position performs unexpectedly, Windtree Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Windtree Therapeutics will offset losses from the drop in Windtree Therapeutics' long position.| Ambrx Biopharma vs. Immix Biopharma | Ambrx Biopharma vs. Cns Pharmaceuticals | Ambrx Biopharma vs. Sonnet Biotherapeutics Holdings | Ambrx Biopharma vs. Enveric Biosciences |
| Windtree Therapeutics vs. Palisade Bio | Windtree Therapeutics vs. Lixte Biotechnology Holdings | Windtree Therapeutics vs. Avenue Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |